Scarica l'app Stockscreener
2.26
6.22%
-0.15
Zentalis Pharmaceuticals Inc Borsa (ZNTL) Ultime notizie
Zentalis Pharmaceuticals Announces First Overall Survival Data for Azenosertib from DENALI Part 1b Published in ESMO Congress 2026 Abstract - GlobeNewswire Inc.
ZNTL Stock Price, Quote & News - Syfe
Certain Stock Options of Zentalis Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 13-OCT-2026. - marketscreener.com
Certain Common Stock of Zentalis Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 13-OCT-2026. - www.marketscreener.com
Leerink Upgrades Zentalis Pharmaceuticals to Outperform From Market Perform, Price Target is $8 - Yahoo Finance
Form 4 Zentalis Pharmaceuticals Llc For: 1 October By Investing.com - Investing.com South Africa
Wells Fargo sets USD 5.00 target for Zentalis Pharmaceuticals stock - AD HOC NEWS
Form 4 Zentalis Pharmaceuticals Llc For: 1 October By Investing.com - Investing.com Nigeria
Form 4 Zentalis Pharmaceuticals Llc For: 1 October By Investing.com - Investing.com UK
At $2.18 a share, Ingmar Bruns acquires 9,727 shares in Zentalis Pharmaceuticals (ZNTL). - Stock Titan
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Zentalis Pharmaceuticals (Nasdaq:ZNTL)Stock Analysis - Simply Wall Street
Zentalis Pharmaceuticals stock gains after ovarian cancer trial update and insider buying - AD HOC NEWS
DarkHorse Technologies Inc. Common Shares (DRK) News Headlines - Nasdaq
William Blair Initiates Zentalis Pharmaceuticals at Outperform - Yahoo Finance
Zentalis at Wells Fargo conference: azenosertib gains clearer path - Investing.com
Zentalis Pharmaceuticals stock gains as investor conferences highlight azenosertib program - ad-hoc-news.de
Zentalis to present at Wells Fargo, Morgan Stanley events | 2026-09-02 | Investing News - stockhouse.com
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewswire
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Four new hires get rights to buy 269,000 Zentalis shares - Stock Titan
Zentalis Pharmaceuticals: Data Due H1 '27 Will Clarify Prospects Of Azenosertib (ZNTL) - Seeking Alpha
Zentalis (ZNTL) Earnings Snapshot: EPS Does Not Reach the Reported Estimate; After Earnings: Shares Move 3.19% HigherEarnings Power Value - vinanet.vn
Zentalis (ZNTL) Q2 2026 Results: Reported EPS Misses Expectations in the Available Record; Share Move: The Stock Ends Down 1.70% in the Current UpdateReturn On Capital - vinanet.vn
Zentalis (ZNTL) Results Check: The EPS Result Is Below Expectation in the Available Record; Price Reaction: The Stock Records a 0.39% Decrease in the Available RecordEarnings Turnaround - vinanet.vn
Zentalis (ZNTL) Earnings Report: EPS Does Not Reach the Reported Estimate on the Day; Stock Move: The Share Price Adds 0.52% in the Latest ReadingFiscal Year Earnings - vinanet.vn
Zentalis Pharmaceuticals Insider Bought Shares Worth $15,172,500, According to a Recent SEC Filing - Yahoo Finance
Zentalis Pharmaceuticals(ZNTL.US) 10% Shareholder Buys US$15.17 Million in Common Stock - Moomoo
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Major Shareholder Group Walters Buys 4,335,000 Shares of Stock - MarketBeat
Walters Group acquires $15.17 million in Zentalis Pharmaceuticals stock - Investing.com
Nearly one-fifth of Zentalis (NASDAQ: ZNTL) sits with one investor group - Stock Titan
Zentalis Pharma closes $92.6 million public offering - The Pharma Letter
Zentalis Pharmaceuticals closes $92.6 million stock offering By Investing.com - Investing.com Canada
Zentalis Pharmaceuticals closes $92.6 million stock offering By Investing.com - Investing.com South Africa
Zentalis Pharmaceuticals closes $92.6 million stock offering By Investing.com - Investing.com Nigeria
Zentalis Pharmaceuticals closes $92.6 million stock offering - Investing.com
Zentalis Pharmaceuticals closes $92.6 million stock offering By Investing.com - Investing.com India
Zentalis Pharmaceuticals closes $92.6 million stock offering By Investing.com - Investing.com UK
Zentalis Pharmaceuticals Announces Closing of Underwritten Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares - The Manila Times
Zentalis Pharmaceuticals Announces Closing of Underwritten - GlobeNewswire
GSA Capital Partners LLP Buys New Shares in Zentalis Pharmaceuticals, Inc. $ZNTL - MarketBeat
Zentalis Pharmaceuticals Closes Offering of Common Shares - Yahoo Finance
Zentalis prices $80.5M stock offering to fund ovarian cancer drug - Dealroom
Zentalis raises $92.6M for trials, filings and what follows - Stock Titan
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Zentalis Pharmaceuticals Shares Fall After Pricing $80.5 Million Offering to Fund Clinical Pipeline - marketscreener.com
7.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):